search
close_mark

Punya Abbhi

Punya Abbhi

26 Jun, 2025

At Celegence, Punya is focused on realizing our vision for increasing efficiency through technology.

Punya’s key responsibility is overseeing the development of our MDR/IVDR compliance platform, CAPTIS®, as well as our Dossplorer™/Dosscriber™ solutions which unlock efficiencies in management of data and documents for the pharmaceutical industry.

Dimitar Stoyanov
Read Now

Other Related Articles

AI-Enabled Clinical Evaluation Reports (CERs): Ensuring Predictable Costs Year After Year
Blog Medical Devices

AI-Enabled Clinical Evaluation Reports (CERs): Ensuring Predictable Costs Year After Year

09 Sep, 2026

How Small Biopharma Companies Can Build a Global CMC Strategy from Day One
Blog Pharmaceutical

How Small Biopharma Companies Can Build a Global CMC Strategy from Day One

09 Sep, 2026

Will Your Next FDA or EMA Question Delay Approval?
Blog Pharmaceutical

Will Your Next FDA or EMA Question Delay Approval?

09 Sep, 2026

Human Expertise at Scale: Why the Future of CMC Is AI-Assisted, Expert-Led
Blog Pharmaceutical

Human Expertise at Scale: Why the Future of CMC Is AI-Assisted, Expert-Led

03 Sep, 2026

Predictable CMC Costs Over Multi-Year Programs: Why Partnership Beats Project-by-Project Outsourcing
Blog Pharmaceutical

Predictable CMC Costs Over Multi-Year Programs: Why Partnership Beats Project-by-Project Outsourcing

03 Sep, 2026

Regulatory Expertise and AI Acceleration: The Formula for Better CER Outcomes
Blog Medical Devices

Regulatory Expertise and AI Acceleration: The Formula for Better CER Outcomes

28 Aug, 2026

Why Regulatory Strategy Is a Capital Allocation Decision
Blog Pharmaceutical

Why Regulatory Strategy Is a Capital Allocation Decision

27 Aug, 2026

The Hidden Cost of Regulatory Uncertainty and Missed Opportunity in Emerging Biotech
Blog Pharmaceutical

The Hidden Cost of Regulatory Uncertainty and Missed Opportunity in Emerging Biotech

26 Aug, 2026

View All